PRTA : Summary for Prothena Corporation plc - Ordi - Yahoo Finance

U.S. Markets open in 3 hrs 21 mins

Prothena Corporation plc (PRTA)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
47.81+0.42 (+0.89%)
At close: 4:00PM EST
People also watch
PTLAPTCTAGIOALDRRARE
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close47.39
Open0.00
Bid0.10 x 100
Ask60.00 x 100
Day's Range46.00 - 47.88
52 Week Range28.20 - 68.18
Volume319,599
Avg. Volume382,612
Market Cap1.65B
Beta3.17
PE Ratio (TTM)-13.65
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : January 10, 2017
    Capital Cube9 days ago

    Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : January 10, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Prothena Corp. Plc a score of 18. Our analysis is based on comparing Prothena Corp. Plc with the following peers – Alkermes Plc, Mallinckrodt Plc, Shire PLC Sponsored ADR, Alnylam Pharmaceuticals, Inc and Amarin Corporation Plc Sponsored ADR (ALKS-US, MNK-US, SHPG-US, ALNY-US and AMRN-US). Investment Outlook Prothena ... Read more (Read more...)

  • Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : January 9, 2017
    Capital Cube10 days ago

    Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : January 9, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • GlobeNewswire15 days ago

    Prothena to Participate in the J.P. Morgan Healthcare Conference

    DUBLIN, Ireland, Jan. 04, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ...